Low-dose radiation followed by on-target inhibition of Galectin-3 in combination with anti-4-1BB monoclonal antibody regulates immune responses in Group 3 and Group 4 medulloblastoma mouse model

Ixekizumab-associated transverse myelopathy in a patient with psoriatic arthritis